Earnings Release • Feb 15, 2024
Earnings Release
Open in ViewerOpens in native device viewer
Elopak is a leading global supplier of liquid carton packaging and filling equipment. We use renewable, recyclable and sustainably sourced materials to provide innovative packaging solutions. Our iconic Pure-Pak® cartons are designed with the environment, safety, and convenience front of mind. They offer a natural and convenient alternative to plastic bottles and fit within a low carbon circular economy.
As worldwide makers of carton-based packaging, we are committed to remaining our customers' partner and the consumers' favorite, through relentlessly developing new solutions for an expanding range of content. Applying market-leading technology, skills, and natural material sourcing, we always aim to provide the highest quality products that leave the world unharmed.
Elopak was founded in Norway in 1957. Today, Elopak has its head office in Oslo, employs 2,700 people and sells in excess of 14 billion cartons every year across more than 70 countries. Our customers are private companies in food and retail. Elopak is a UN Global Compact participant member. We have set Science Based Targets to reduce emissions in line with the 1.5-degree trajectory and aim to be Net-Zero by 2050. In 2023, we achieved a gold rating by EcoVadis and were rated top 2% sustainable companies in the world.
As worldwide makers of carton-based packaging, we are committed to remaining our customers' partner and the consumers' favorite, through relentlessly developing new solutions for an expanding range of content.
Applying market-leading technology, skills and natural material sourcing, we always aim to provide the highest quality products that leave the world unharmed.
| Quarter ended December 31. | Year to date ended December 31. | ||||||
|---|---|---|---|---|---|---|---|
| (EUR 1.000.000) | 2023 | 2022 | Change | 2023 | 2022 | Change | |
| Revenue | 287.2 | 267.2 | 7% | 1,132.0 | 1,023.7 | 11% | |
| EBITDA1) | 37.4 | 34.3 | 9% | 164.1 | 109.9 | 49% | |
| Adjusted EBITDA1) | 40.0 | 35.9 | 11% | 170.9 | 119.4 | 43% | |
| Adjusted EBITDA margin1) | 13.9 % | 13.5 % | 4% | 15.1 % | 11.7 % | 29% | |
| Profit from continuing operations | 13.5 | 11.2 | 20% | 69.4 | 34.2 | 103% | |
| Adjusted profit attributable to Elopak shareholders1) | 13.5 | 11.8 | 15% | 68.3 | 44.0 | 55% | |
| Net interest bearing debt1) (NIBD) | 332.5 | 391.5 | -15% | 332.5 | 391.5 | -15% | |
| Leverage ratio1) | 1.9 | 3.3 | - | 1.9 | 3.3 | - | |
| Adjusted basic and diluted earnings per share (in EUR) | 0.05 | 0.04 | - | 0.25 | 0.16 | - |
1) See definition of Alternative Performance Measures, including specification of adjustments, at the end of this report
Adjusted EBITDA (EURm) and margin (%)
2023 was a year of significant progress and achievements for Elopak, extending the many successes of previous years in implementing our sustainability driven growth strategy. Elopak rounded off a successful year with yet another strong quarter.
Q4 has been an eventful period for our business in Americas. We signed major contracts with new and existing customers and helped supply the US school milk market in a time of abrupt school milk supply shortage. In response to the growth opportunities we see for Americas, we announced Little Rock, Arkansas as the location for our new production plant in the US. The new location will provide green energy, efficient access to suppliers, and a great transportation network. Production is expected to begin in the first half of 2025, adding over 100 new skilled professionals to our global network.
In EMEA, the persistent inflationary pressures continue to have a negative effect on consumption. We follow the development closely while continuing to invest in innovation so as to expand our portfolio of filling machines and cartons. In Q4, we commissioned several new filling machines, and rolled out our next generation filling machine for fresh liquid products. Our new machine operates at an exceptional hygiene standard that gives fresh products a shelf life of up to 60 days. Extended shelf life means less food waste and an easier way for the consumer to choose environmentally friendly packaging for their fresh milk or juice products.
In the Middle East and North Africa (MENA), we have successfully managed to maintain our volumes and improve our profitability throughout the year. In Q4, I am happy to see signs that both milk production and dairy consumption are recovering, and we are looking forward to improving our business in the MENA region further.
Increased focus on sustainability from regulators, companies and consumers is resulting in many of our customers moving from plastic to carton packaging. One example is Yoplait, which has now chosen the 750 ml Pure-Pak® eSense carton over plastic for their yoghurts. Yoplait is the first dairy brand to launch spoonable yoghurts in cartons in France. This means that plastic is reduced by 75% compared to their previous plastic packaging solution.
2023 marked 15 years of structured sustainability work in Elopak, leading to a significant reduction in the average carbon footprint of our cartons from innovations such as renewable PE, brown board, and Pure-Pak® eSense. Most recently, we are pleased to report 20% decrease in scope 1 and 2 greenhouse gas emissions from 2020, as well as a 7% reduction in value chain (scope 3) emissions. These developments reflect our continued commitment to environmental, societal, and ethical excellence in our journey towards becoming a net zero company by 2050.
In 2023, Elopak achieved 9.4% organic revenue growth and 15.1% adjusted EBITDA margin for the full year. During the year we have improved our capital structure by repaying debt on the back of strong cash from operations. Consequently, the leverage ratio at the end of year was 1.9x, which is a significant improvement from the level of 3.3x reported in 2022.
Going forward, we continue to pay close attention to how inflationary pressures and interest rates impact consumption and consumer behavior. The turbulent macroeconomic and geopolitical conditions have resulted in supply chain challenges that affect our industry, a situation that we expect will gradually improve. We will continue to manage volatility in our raw material exposure to protect our margins, and we expect our strategic initiatives to grow our topline further. In 2024, the construction of our new production plant in the US will be a high priority as we are committed to ensuring completion within time and budget, while adhering to the highest standards of quality and safety.
I am pleased to confirm that the Elopak team has delivered on all the targets set in the IPO in 2021, and looking back, I would like to say a big thank you to all our colleagues, customers, suppliers and partners for their fantastic contributions and collaboration throughout the year. We are entering 2024 from a strong position and I look forward to further strengthening our contribution to a more sustainable society while continuing to create shareholder value in the years to come.
I am happy to report yet another quarter with strong performance and I am pleased to confirm that the Elopak team has delivered on all the 3-5 year targets set in the IPO in 2021. We are entering 2024 from a strong position and I look forward to further strengthening our contribution to a more sustainable society while continuing to create shareholder value in the years to come.
Thomas Körmendi Chief Executive Officer - CEO
In the fourth quarter of 2023, revenues increased by 7.5% compared to the same period last year, or EUR 20.0 million. Adjusting for currency fluctuations, the increase was 8.4%, or EUR 22.4 million.
In EMEA, revenues grew by EUR 21.2 million (10.7%) compared to the same quarter last year. The revenue development in the quarter was mainly a result of price adjustments in the beginning of the year, as well as an increase in sale of filling machines. In terms of volumes, the development in the quarter was satisfactory given the current macro-economic situation. Roll Fed volumes continued to increase from ramp-up in India, as well as market share gains in Europe. Pure-Pak® Fresh and Aseptic volumes remained stable versus the comparable period. In MENA, volumes have successfully recovered after a slow start to the year, and the region has benefitted from improved fundamentals in the dairy segment.
The Americas business continued to perform well, with total revenue growth of EUR 7.7 million (10.7%) compared to the fourth quarter of 2022. The growth was mostly driven by increased sale of filling machines, as well as volume growth from organic customer base. Furthermore, the region
also benefitted from new customers, with positive development within the fresh dairy segment.
Full year 2023, Group revenues increased by 10.6%, or EUR 108.3 million. Adjusting for currency fluctuation and acquisition effects, revenue growth is 9.4%, or EUR 96.4 million.
In EMEA, full year revenues increased EUR 84.4 million (10.7%) compared to last year with an organic revenue growth of EUR 64.7 million, adjusted for currency translation and acquisition effects. The main drivers behind the organic revenue growth were improved pricing, higher Roll Fed volumes, as well as the increased number of filling machines sold.
In Americas, full year revenues increased by EUR 30.1 million (11.6%) compared to last year. The organic revenue growth was EUR 37.9 million, mainly a result of volume growth in the Fresh Dairy and Juice segment from onboarding of new customers, favorable product mix and price increases from pass-through of raw material cost increases. Currency translation effects had a EUR 7.8 million negative impact, due to weakening of the USD against Euro.
Group Adjusted EBITDA in the fourth quarter of 2023 increased by EUR 4.1 million, from EUR 35.9 million in 2022 to EUR 40.0 million in 2023. The adjusted EBITDA margin was 13.9% (13.5%). During the quarter the company has taken the initiative to improve working capital efficiency, including finished goods inventories. Consequently, the initiative has had a negative effect on the EBITDA with EUR 3.2 million, in compliance with the IFRS15 accounting standard. See more details in note 3.
In EMEA, adjusted EBITDA increased by EUR 0.5 million compared to the same quarter last year. Adjusted EBITDA-margin in the quarter was 12.9% (14.0%). The margin decline was primarily driven by increased sale of filling machines with lower margins, as well as the IFRS15 impact from initiative to reduce finished goods inventory. Without these two components the margin in EMEA would have been 15.1%. Furthermore, higher raw material cost, inflationary impact on salaries and fixed cost impacted profitability, although mitigated by pricing. MENA delivered stable volumes versus the comparable period, and the region has benefitted from operational improvements which, in turn, have improved profitability.
In Americas, adjusted EBITDA increased by EUR 3.7 million compared to the same quarter last year. Adjusted EBITDA-margin was 24.1% (21.6%). The improved margin is primarily a consequence of improved filling machine profitability. Furthermore, the margin reflects both a stronger performance in our joint ventures and an increase in deliveries related to sorting the supply shortage of school milk in the US.
On a year-to-date basis, adjusted EBITDA for the Group increased by EUR 51.5 million (43.1%) to EUR 170.9 million. The increase was mainly a result of the price adjustments in EMEA, onboarding of new customers in Americas, as well as margin accretive growth in new markets. In EMEA, adjusted EBITDA year to date increased by EUR 41.2 million. Adjusted EBITDA margin was 15.6% (12.0%). In Americas adjusted EBITDA increased by EUR 16.0 million. Adjusted EBITDA margin was 23.2% (19.8%).
| Year to date ended | |
|---|---|
| (EUR 1,000) | 2023 | 2022 | Change |
|---|---|---|---|
| Net cash flow from operations | 157,189 | 25 094 | 526% |
| Net cash flow from investing activities | -31,978 | -126,009 | -75% |
| Net cash flow from financing activities | -137,475 | 102,558 | -234% |
| Foreign currency translation on cash | -310 | -22 | 1325% |
| Net increase/decrease in cash | -12,574 | 1,620 | -876% |
in 2023, up by EUR 2.2 million, from EUR 11.2 million in the same period of 2022.
Share of net income from joint ventures was EUR 2.8 million in the quarter, an increase of EUR 1.8 million from the same period in 2022. The improved performance is driven both by higher Pure-Pak® volume and improved margins.
Net Financial expenses increased by EUR 8.3 million compared to last year, with around EUR 5.0 million coming from unrealized fair value losses on interest rate swaps. Net interest settled under the interest rate swaps was EUR 0.9m, reducing the net interest cost in the period. Lower debt in the period has furthermore partially offset the increase in interest rates. The comparable period also had a favorable foreign exchange gain, not repeated in 2023.
Tax expenses for the quarter were EUR 1.8 million, which is a decrease of EUR 2.6 million compared to same period last year. The tax expense in the quarter is impacted favorably by currency translation effects. The expected tax at current statutory tax rates for the Group is approximately 24%, depending on the relative mix of profits and losses taxed at varying rates in the jurisdictions in which Elopak operates.
The following table provides a reconciliation from reported operating profit to EBITDA and adjusted EBITDA. For further details and definitions, please refer to the APM section in the back of this report.
In the fourth quarter of 2023, operating profit increased by EUR 6.1 million, from EUR 16.1 million to EUR 22.3 million in 2023. The development is primarily a result of the factors explained in the adjusted EBITDA section, as well as depreciation and amortization that was EUR 2.2 million lower. Depreciation and amortization were higher in the comparable period of 2022 mainly due to intangible assets from the Naturepak acquisition, which are now fully amortized.
Year to date operating profit increased by EUR 61.0 million to EUR 102.8 million. The development is mainly a result of the factors explained above in the adjusted EBITDA section. Additionally, the comparable period was affected negatively from impairment in Ukraine and transactions costs related to acquisition of Naturepak and GLS.
In the fourth quarter of 2023, profit after tax from continuing operations increased to EUR 13.5 million
2) Share of net income and impairment on investment from joint ventures included in adjusted figures 3) See reconciliation of net income from joint ventures
| Quarter ended December 31, |
Year to date ended December 31, |
||||
|---|---|---|---|---|---|
| (EUR 1,000) | 2023 | 2022 | 2023 | 2022 | |
| Operating profit | 22,253 | 16,105 | 102,779 | 41,774 | |
| Depreciation, amortisation and impairment adjusted | 15,113 | 17,745 | 61,332 | 63,938 | |
| Impairment fixed and long term assets Ukraine | - | 412 | - | 4,189 | |
| EBITDA | 37,366 | 34,262 | 164,111 | 109,901 | |
| Total adjusted items with EBITDA impact | -100 | 690 | -100 | 5,134 | |
| Share of net income from joint ventures (continued operations) 2) 3) | 2,753 | 991 | 6,855 | 4,378 | |
| Adjusted EBITDA | 40,019 | 35,943 | 170,867 | 119,413 |
Profit after tax from continued operations for the full year increased by EUR 35.1 million, in line with the development of the operating result and the increase in financial and income tax expense.
For the full-year 2023, cash flow from operations was EUR 157.2 million, mainly driven by strong earnings, as well as targeted initiatives improving the Group cash from working capital.
Net cash flow used in investing activities was EUR -32.0 million, reflecting a slightly lower than average level of leased filling machines and a normal level of manufacturing plant projects in Europe and Americas. Furthermore, Elopak received installments from the sale of its Russian subsidiary amounting to EUR 4.9 million, as well as dividends from Joint Ventures of EUR 2.0 million. In the comparable period the main investment was the acquisition of Naturepak and GLS India.
Net cash flow from financing activities was EUR -137.5 million, reflecting down payment on bank loans of EUR 80.0 million, dividends paid to our shareholders of EUR 19.6 million, interest expenses of EUR 11.3 million and lease payments of EUR 18.4 million.
Net interest-bearing bank debt has decreased from EUR 300.8 million at year end 2022 to EUR 231.0 million as of end of December. The main reason for the decrease is strong cash flow from operations year to date. In 2023, lease liability according to IFRS 16 increased by EUR 10.8 million to EUR 101.5 million due to new tethered caps contracts. Consequently, the Leverage Ratio as of December 31, 2023 was 1.9x which is a significant improvement from 3.3x reported as of December 31, 2022.
For a specification of the net debt, please refer to the APM section.
Equity increased by EUR 47.5 million, from EUR 268.0 million as of December 31, 2022, to EUR 315.3 million as of December 31, 2023. Total comprehensive income was EUR 66.4 million.
The Board confirms that the accounts are presented under a going concern assumption.
Condensed consolidated quarterly financial statements
| Quarter ended December 31 Year to date ended December 31 | ||||||
|---|---|---|---|---|---|---|
| (EUR 1,000) | Note | 2023 | 2022 | 2023 | 2022* | |
| Revenues | 3 | 287,166 | 267,057 | 1,132,043 | 1,023,696 | |
| Other operating income | 17 | 99 | 145 | 157 | ||
| Total income | 4 | 287,183 | 267,156 | 1,132,187 | 1,023,853 | |
| Cost of materials | -187,216 | -173,911 | -719,796 | -681,474 | ||
| Payroll expenses | 5 | -48,627 | -44,802 | -189,623 | -176,721 | |
| Depreciation and amortization expenses | 6 | -14,495 | -16,723 | -60,147 | -61,528 | |
| Impairment of non-current assets | -618 | -1,434 | -1,186 | -6,599 | ||
| Other operating expenses | -13,974 | -14,180 | -58,658 | -55,757 | ||
| Total operating expenses | -264,930 | -251,051 | -1,029,409 | -982,079 | ||
| Operating profit | 4 | 22,253 | 16,105 | 102,778 | 41,774 | |
| Financial income and expenses | ||||||
| Share of net income from joint ventures | 2,753 | 991 | 6,855 | 4,378 | ||
| Financial income | 723 | 1,195 | 7,807 | 10,305 | ||
| Financial expenses | -10,395 | -4,802 | -32,064 | -13,033 | ||
| Foreign exchange gain/loss | -24 | 2,192 | -498 | 2,983 | ||
| Profit before tax from continuing operations | 15,311 | 15,681 | 84,880 | 46,407 | ||
| Income tax | 7 | -1,843 | -4,461 | -15,513 | -12,188 | |
| Profit from continuing operations | 13,468 | 11,220 | 69,366 | 34,220 | ||
| Discontinued operations Russia | - | - | -1,339 | -23,622 | ||
| Profit/loss from discontinued operations | - | - | -1,339 | -23,622 | ||
| Profit/loss | 13,468 | 11,220 | 68,027 | 10,598 | ||
| Profit attributable to: | ||||||
| Elopak shareholders | 13,586 | 10,940 | 67,061, | 10,856 | ||
| Non-controlling interest | -118 | 280 | 966 | -259 | ||
| Basic and diluted earnings per share from continuing operations (in EUR) |
0.05 | 0.04 | 0.25 | 0.13 | ||
| Basic and diluted earnings per share from discontinued operations (in EUR) |
0.00 | 0.00 | 0.00 | -0.09 | ||
| Basic and diluted earnings per share attributable to Elopak shareholders (in EUR) |
0.05 | 0.04 | 0.25 | 0.04 |
| (EUR 1,000) | Quarter ended December 31 |
Year to date ended December 31 |
||
|---|---|---|---|---|
| OTHER COMPREHENSIVE INCOME | 2023 | 2022 | 2023 | 2022* |
| Items that will not be reclassified subsequently to profit or loss | ||||
| Actuarial gains/losses on defined benefit pension plans, net of tax | -135 | -27 | -81 | 20 |
| Items reclassified subsequently to net income upon derecognition | ||||
| Exchange differences on translation foreign operations Elopak shareholders | -4,903 | -15,183 | 375 | 6,406 |
| Exchange differences on translation foreign operations non-controlling interest | -419 | -852 | -383 | -467 |
| Net value gains/losses on cash flow hedges, net of tax | -220 | 624 | -1,517 | -6,972 |
| Other comprehensive income, net of tax | -5,677 | -15,438 | -1,606 | -1,013 |
| Total comprehensive income | 7,790 | -4,218 | 66,421 | 9,585 |
| Total comprehensive income attributable to: | ||||
| Elopak shareholders | 8,328 | -4,031 | 65,838 | 10,310 |
| Non-controlling interest | -538 | -187 | 583 | -726 |
*Audited
Skøyen, February 14, 2024
| (EUR 1,000) | December 31, | December 31, | |
|---|---|---|---|
| ASSETS Note |
2023 | 2022* | |
| Non-current assets | |||
| Development cost and other intangible assets | 62,300 | 71,331 | |
| Deferred tax assets | 22,883 | 22,414 | |
| Goodwill | 106,061 | 104,958 | |
| Property, plant and equipment | 202,934 | 201,975 | |
| Right-of-use assets | 6 | 86,370 | 76,784 |
| Investment in joint ventures | 37,709 | 34,673 | |
| Other non-current assets | 14,892 | 19,841 | |
| Total non - current assets | 533,149 | 531,976 | |
| Current assets | |||
| Inventory | 192,189 | 187,207 | |
| Trade receivables | 110,243 | 102,197 | |
| Other current assets | 113,720 | 109,214 | |
| Cash and cash equivalents | 13,308 | 25,883 | |
| Total current assets | 429,460 | 424,502 | |
| Total assets | 4 | 962,610 | 956,479 |
*Audited
| (EUR 1,000) | December 31, December 31, | ||
|---|---|---|---|
| EQUITY AND LIABILITIES | Note | 2023 | 2022* |
| EQUITY | |||
| Share capital | 8 | 50,104 | 50,155 |
| Other paid-in capital | 8 | 70,548 | 69,987 |
| Currency translation reserve | -27,103 | -27,477 | |
| Cash flow hedge reserve | -4,275 | -2,758 | |
| Retained earnings | 216,977 | 169,584 | |
| Attributable to Elopak shareholders | 306,253 | 259,491 | |
| Non-controlling interest | 9,043 | 8,477 | |
| Total equity | 315,296 | 267,967 | |
| LIABILITIES | |||
| Non-current liabilities | |||
| Pension liabilities | 2,502 | 2,668 | |
| Deferred taxes | 7 | 14,041 | 17,240 |
| Non-current liabilities to financial institutions | 224,433 | 304,033 | |
| Non-current lease liabilities | 78,424 | 73,536 | |
| Other non-current liabilities | 5,033 | 1,867 | |
| Total non-current liabilities | 324,434 | 399,344 | |
| Current liabilities | |||
| Current liabilities to financial institutions | 19,333 | 21,682 | |
| Trade payables | 127,847 | 124,038 | |
| Taxes payable | 6,997 | 2,198 | |
| Public duties payable | 25,066 | 22,682 | |
| Current lease liabilities | 23,096 | 17,139 | |
| Other current liabilities | 120,540 | 101,429 | |
| Total current liabilities | 322,880 | 289,167 | |
| Total liabilities | 647,314 | 688,512 | |
| Total equity and liabilities | 962,610 | 956,479 |
*Audited
Sanna Suvanto-Harsaae
Board member
Trond Solberg
Håvard Grande Urhamar
Board member
Anna Belfrage Board member
Anette Bauer Ellingsen
Board member
Sid Johari Board member
Thomas Körmendi CEO
Dag Mejdell
Chairperson
| Year to date ended December 31 | ||
|---|---|---|
| (EUR 1,000) | 2023 | 2022* |
| Profit before tax from: | ||
| Continuing operations | 84,880 | 46,407 |
| Discontinued operations | -1,339 | -22,825 |
| Profit before tax (including discontinued operations) | 83,540 | 23,583 |
| Interest to financial institutions Lease liability interest |
11,303 6,566 |
5,658 4,575 |
| Profit before tax and interest paid | 101,410 | 33,815 |
| Depreciation, amortization and impairment losses | 61,332 | 76,118 |
| Net gains(-), losses from disposals, impairments and change in fair value of financial assets and liabilities | -399 | 500 |
| Net unrealized currency gain(-)/loss | -174 | 2,297 |
| Income from joint ventures | -6,855 | -4,378 |
| Net gain(-)/loss on sale of non-current assets | -13 | 137 |
| Income taxes paid | -14,270 | -13,683 |
| Change in trade receivables | -9,275 | -10,615 |
| Change in other current assets | -5,265 | -16,391 |
| Change in inventories | -6,982 | -39,175 |
| Change in trade payables | 3,897 | 4,893 |
| Change in other current liabilities Change in net pension liabilities |
34,011 -228 |
-8,117 -307 |
| Net cashflow from operating activities | 157,189 | 25,094 |
| Purchase of non-current assets | -40,774 | -43,714 |
| Acquisition of subsidiaries and joint ventures | - | -88,262 |
| Proceeds from sale of non-current assets | 122 | 1,232 |
| Proceeds from sale of financial assets and businesses | 4,883 | - |
| Dividend from joint ventures | 2,018 | - |
| Change in other non-current assets | 1,772 | 4,735 |
| Net cash flow from investing activities | -31,978 | -126,009 |
| Proceeds of loans from financial institutions | 1,087,304 | 1,178,067 |
| Repayment of loans from financial institutions | -1,174,598 | -1,030,217 |
| Interest to financial institutions | -11,303 | -5,658 |
| Lease payments | -18,359 | -19,770 |
| Dividend paid to equity holders of Elopak ASA | -19,634 | -19,623 |
| Purchase of treasury shares | -885 | -241 |
| Net cash flow from financing activities | -137,475 | 102,558 |
| Effects of exchange rate changes on cash and cash equivalents | -310 | -22 |
| Net change in cash and cash equivalents | -12,574 | 1,621 |
| Cash and cash equivalents at the beginning of the year | 25,883 | 24,262 |
*Audited
(EUR 1,000)
| Currency | ||||||||
|---|---|---|---|---|---|---|---|---|
| Other | trans | Cash flow | Non-con | |||||
| Share | paid-in | lation | hedge | Retained | trolling | Total | ||
| December 31, 2023 | Note | capital | capital | reserve | reserve | earnings | interest | equity |
| Total equity 01.01 | 50,155 | 69,987 | -27,477 | -2,758 169,584 | 8,477 | 267,967 | ||
| Profit for the period | - | - | - | - | 67,061 | 966 | 68,027 | |
| Other comprehensive income for the | - | - | 375 | -1,517 | -81 | -383 | -1,606 | |
| period net of tax | ||||||||
| Total comprehensive income for the period | - | - | 375 | -1,517 66,980 | 583 | 66,421 | ||
| Dividend paid | - | - | - | - -19,634 | -16 | -19,650 | ||
| Share based payments | - | 1,100 | - | - | 47 | - | 1,146 | |
| Treasury shares | -50 | -539 | - | - | - | - | -589 | |
| Total capital transactions in the period | 8 | -50 | 561 | - | - -19,587 | -16 -19,093 | ||
| Total equity 31.12 | 50,104 | 70,548 | -27,103 | -4,275 | 216,977 | 9,043 | 315,296 |
| Currency | |||||||
|---|---|---|---|---|---|---|---|
| December 31, 2022* | Other | trans | Cash flow | Non-con | |||
| Share | paid-in | lation | hedge | Retained | trolling | Total | |
| (EUR 1,000) Note |
capital | capital | reserve | reserve | earnings | interest | equity |
| Total equity 01.01 | 50,155 | 70,236 | -33,883 | 4,215 | 178,330 | - 269,054 | |
| Profit for the period | - | - | - | - | 10,856 | -259 | 10,598 |
| Other comprehensive income for the period net of tax | - | - | 6,406 | -6,972 | 20 | -467 | -1,013 |
| Total comprehensive income for the period | 6,406 | -6,972 | 10,877 | -726 | 9,584 | ||
| Dividend paid | - | - | - | - | -19,623 | - | -19,623 |
| Settlement of share-based bonus 2021 | - | -330 | - | - | - | - | -330 |
| Provision for share-based bonus 2022 | - | 89 | - | - | - | - | 89 |
| Acquisition of GLS Elopak | - | - | - | - | - | 9,202 | 9,202 |
| Treasury shares | -1 | -9 | - | - | - | - | -10 |
| Total capital transactions in the period | -1 | -250 | - | - | -19,623 | 9,202 | -10,672 |
| Total equity 31.12 | 50,155 | 69,987 | -27,477 | -2,758 | 169,584 | 8,477 | 267,967 |
*Audited
The Elopak Group consists of Elopak ASA and its subsidiaries. Elopak ASA is a public limited company incorporated in Norway and listed on Oslo Stock Exchange. The Elopak Group is a leading global supplier of carton packaging and filling equipment, which supplies both the fresh and aseptic segments. The consolidated financial information has not been subject to audit or review.
All numbers are presented in EUR 1,000 unless otherwise is clearly stated. The subtotals in some of the tables may not equal the sum of the amounts shown due to rounding. Certain amounts in the comparable periods in the note disclosures have been reclassified to conform to current period presentation.
The Board of Directors approved the condensed consolidated interim financial statements for the period ended December 31, 2023 on February 14, 2024.
The condensed consolidated interim financial statements have been prepared in accordance with IFRS® Accounting Standards, IAS 34 "Interim Financial Reporting". The condensed interim financial statements do not include all information and disclosures required in the annual financial statement and should be read in conjunction with the Group's Annual Report for 2022, which has been prepared according to IFRS as adopted by EU. The accounting policies applied in the preparation of the consolidated interim financial statements are consistent with those applied in the preparation of the annual IFRS financial statements for the year ended December 31, 2022.
The preparation of interim financial statements requires the Group to make certain estimates and assumptions that affect the application of accounting policies and reported amounts of assets, liabilities, income, and expenses. Estimates and judgements are continually evaluated by the company based on historical experience and other factors, including expectations of future events that are deemed to be reasonable under the circumstances. Actual results may differ from these estimates. The most significant judgements used in preparing these interim financial statements and the key areas of estimation uncertainty are the same as those applied in the consolidated annual report for 2022.
The annual report for 2022 provides a description of the uncertainties and risks for the business.
| Quarter ended December 31 Year to date ended December 31 | ||||
|---|---|---|---|---|
| (EUR 1,000) | 2023 | 2022 | 2023 | 2022 |
| USA | 63,498 | 54,444 | 219,203 | 193,839 |
| Germany | 40,516 | 39,251 | 159,778 | 161,629 |
| Canada | 18,803 | 20,010 | 77,705 | 68,778 |
| Netherlands | 13,515 | 15,125 | 58,201 | 56,215 |
| Norway | 5,803 | 6,485 | 27,120 | 25,645 |
| Other | 145,032 | 131,742 | 590,036 | 517,589 |
| Total revenue | 287,166 | 267,057 | 1,132,043 | 1,023,696 |
The revenues are specified by location (country) of the customer.
The Group's revenues consist of revenue from contracts with customers (99%) and rental income from lease of filling equipment (1%). Revenues are primarily derived from the sale of cartons and closures, sales and rental income related to filling equipment and service. The tables include continuing operations only.
As described in the accounting policy for revenues in the annual report for 2022, and in compliance with IFRS 15, the Group recognizes revenue over time for goods without alternative use where the Group has a legally enforceable right to payment. This gives a positive effect on revenue and EBITDA in times where the inventory level of such goods is increasing and negative effect in times where the inventory level of such goods is decreasing. The impact on EBITDA for the quarter is EUR -3.2 million for 2023 and EUR 0.7 million for 2022. The impact on EBITDA for the year is EUR 2.8 million for 2023 and EUR 2.6 million for 2022.
| Other and | ||||
|---|---|---|---|---|
| Year to date ended December 31, 2023 | EMEA | Americas | eliminations | Total |
| Cartons and closures | 755,682 | 276,739 | -4,245 | 1,028,177 |
| Equipment | 52,385 | 12,114 | -14,227 | 50,272 |
| Service | 52,113 | - | -971 | 51,142 |
| Other | 10,278 | 1,748 | -9,575 | 2,451 |
| Total revenue | 870,459 | 290,601 | -29,016 | 1,132,043 |
| Other and | ||||
|---|---|---|---|---|
| Year to date ended December 31, 2022 | EMEA | Americas | eliminations | Total |
| Cartons and closures | 671,025 | 256,522 | -3,797 | 923,750 |
| Equipment | 36,307 | 2,183 | -9,907 | 28,583 |
| Service | 46,036 | - | -669 | 45,367 |
| Other | 32,608 | 1,830 | -8,442 | 25,996 |
| Total revenue | 785,976 | 260,535 | -22,815 | 1,023,696 |
Information reported to the Group's chief operating decision makers, the Group Leadership Team, for the purpose of resource allocation and assessment of segment performance is focused on two key geographical regions – EMEA and Americas. Key figures representing the financial performance of these segments are presented in the following note. GLS Elopak is included in EMEA. The tables include continuing operations only.
| (EUR 1,000) | Other and | |||
|---|---|---|---|---|
| Quarter ended December 31, 2023 | EMEA | Americas | eliminations | Total |
| Revenue from contracts with customers | 207,331 | 79,607 | 228 | 287,166 |
| Other income | -66 | 83 | - | 17 |
| Total income from external customers | 207,265 | 79,690 | 228 | 287,183 |
| Revenue from other group segments | 12,141 | 766 | -12,908 | - |
| Total income | 219,406 | 80,456 | -12,679 | 287,183 |
| Operating expenses 1) | -191,011 | -63,851 | 5,045 | -249,817 |
| Depreciation and amortization | -12,101 | -1,828 | -566 | -14,495 |
| Impairment | -618 | - | - | -618 |
| Operating profit | 15,676 | 14,778 | -8,201 | 22,253 |
| EBITDA 2 ) |
28,395 | 16,605 | -7,634 | 37,366 |
| Adjusted EBITDA 2 ) |
28,292 | 19,362 | -7,634 | 40,019 |
| Total assets | 967,566 | 186,563 | -191,519 | 962,610 |
| Purchase of non-current assets during the quarter | 19,071 | 1,345 | 654 | 21,070 |
| (EUR 1,000) | Other and | |||
|---|---|---|---|---|
| Quarter ended December 31, 2022 | EMEA | Americas | eliminations | Total |
| Revenue from contracts with customers | 194,545 | 72,322 | 190 | 267,057 |
| Other income | 99 | - | - | 99 |
| Total income from external customers | 194,644 | 72,322 | 190 | 267,156 |
| Revenue from other group segments | 3,525 | 385 | -3,910 | - |
| Total income | 198,170 | 72,707 | -3,721 | 267,156 |
| Operating expenses 1) | -171,031 | -58,027 | -3,836 | -232,894 |
| Depreciation and amortization | -14,123 | -1,851 | -749 | -16,723 |
| Impairment | -1,173 | -261 | - | -1,434 |
| Operating profit | 11,843 | 12,568 | -8,306 | 16,105 |
| EBITDA 2) | 27,139 | 14,680 | -7,557 | 34,262 |
| Adjusted EBITDA 2) | 27,767 | 15,694 | -7,519 | 35,943 |
| Total assets | 945,626 | 157,111 | -146,258 | 956,479 |
| Purchase of non-current assets during the quarter | 12,761 | 819 | 672 | 14,253 |
"1) Operating expenses include cost of materials, payroll expenses, and other operating expenses. 2) See the APM disclosure for the reconciliation of EBITDA and adjusted EBITDA."
| Other and | ||||
|---|---|---|---|---|
| Quarter ended December 31, 2022 | EMEA | Americas | eliminations | Total |
| Cartons and closures | 170,345 | 72,274 | -970 | 241,649 |
| Equipment | 6,072 | 31 | -84 | 6,019 |
| Service | 11,748 | - | -239 | 11,509 |
| Other | 9,906 | 403 | -2,429 | 7,878 |
| Total revenue | 198,072 | 72,707 | -3,722 | 267,057 |
(EUR 1,000)
| Other and | ||||
|---|---|---|---|---|
| Quarter ended December 31, 2023 | EMEA | Americas | eliminations | Total |
| Cartons and closures | 177,819 | 71,471 | -1,106 | 248,184 |
| Equipment | 25,337 | 8,121 | -8,279 | 25,179 |
| Service | 13,594 | - | -163 | 13,431 |
| Other | 2,723 | 780 | -3,131 | 371 |
| Total revenue | 219,473 | 80,373 | -12,679 | 287,166 |
The Group leases several assets including buildings, plants, cars and filling machines.
| Right-of-use assets | ||||
|---|---|---|---|---|
| (EUR 1,000) | Property and | Office and | ||
| December 31, 2023 | buildings | Machinery | transport | Total |
| Carrying amount 1.1 | 52,148 | 13,968 | 10,668 | 76,784 |
| Additions and adjustments | 3,896 | 16,043 | 3,261 | 23,200 |
| Disposals | -6 | -33 | -111 | -151 |
| Current year depreciation charge | -4,442 | -5,177 | -3,844 | -13,463 |
| Carrying amount at 31.12 | 51,596 | 24,800 | 9,974 | 86,370 |
| (EUR 1,000) | Property and | Office and | ||
|---|---|---|---|---|
| December 31, 2022 | buildings | Machinery | transport | Total |
| Carrying amount 1.1 | 38,652 | 12,986 | 11,314 | 62,952 |
| Additions and adjustments | 22,258 | 6,307 | 3,278 | 31,842 |
| Disposals | -3,956 | -28 | -100 | -4,084 |
| Current year depreciation charge | -4,806 | -5,288 | -3,823 | -13,918 |
| Impairment losses | - | -8 | - | -8 |
| Carrying amount at 31.12 | 52,148 | 13,968 | 10,668 | 76,784 |
The Group has one significant purchase option for the purchase of the High Bay warehouse lease agreement. This purchase option can be exercised in 2042 and the purchase price is market value at exercise date. An exercise of the purchase option is not considered to be reasonably certain, hence it is not recognized.
In 2023, expenses related to short-term leases were EUR 20 thousand, expenses related to low value assets were EUR 610 thousand and expenses related to variable payments not included in the measurement of lease liabilities were EUR 222 thousand.
| Other and | ||||
|---|---|---|---|---|
| Year to date ended December 31, 2023 | EMEA | Americas | eliminations | Total |
| Revenue from contracts with customers | 842,304 | 288,882 | 857 | 1,132,043 |
| Other income | 61 | 83 | - | 145 |
| Total income from external customers | 842,365 | 288,965 | 857 | 1,132,187 |
| Revenue from other group segments | 28,153 | 1,718 | -29,872 | - |
| Total income | 870,519 | 290,684 | -29,015 | 1,132,187 |
| Operating expenses 1) | -734,923 | -230,120 | -3,034 | -968,076 |
| Depreciation and amortization | -50,589 | -7,159 | -2,398 | -60,147 |
| Impairment | -1,186 | - | - | -1,186 |
| Operating profit | 83,821 | 53,405 | -34,446 | 102,779 |
| EBITDA 2) | 135,595 | 60,564 | -32,048 | 164,111 |
| Adjusted EBITDA 2) | 135,482 | 67,433 | -32,048 | 170,867 |
| Total assets | 967,566 | 186,563 | -191,519 | 962,610 |
| Purchase of non-current assets during the year | 38,353 | 1,756 | 665 | 40,774 |
| Other and | ||||
|---|---|---|---|---|
| Year to date ended December 31, 2022 | EMEA | Americas | eliminations | Total |
| Revenue from contracts with customers | 764,434 | 258,748 | 514 | 1,023,695 |
| Other income | 157 | - | - | 157 |
| Total income from external customers | 764,592 | 258,748 | 514 | 1,023,853 |
| Revenue from other group segments | 21,542 | 1,787 | -23,329 | - |
| Total income | 786,133 | 260,535 | -22,815 | 1,023,853 |
| Operating expenses 1) | -693,984 | -213,558 | -6,410 | -913,952 |
| Depreciation and amortization | -51,564 | -7,164 | -2,800 | -61,528 |
| Impairment | -6,338 | -261 | - | -6,599 |
| Operating profit | 34,247 | 39,551 | -32,024 | 41,774 |
| EBITDA 2) | 92,149 | 46,976 | -29,224 | 109,901 |
| Adjusted EBITDA 2) | 94,283 | 51,466 | -26,336 | 119,412 |
| Total assets | 945,626 | 157,111 | -146,258 | 956,479 |
| Purchase of non-current assets during the year | 45,006 | 5,657 | -6,949 | 43,714 |
1)Operating expenses include cost of materials, payroll expenses, and other operating expenses. 2)See the APM disclosure for the reconciliation of EBITDA and adjusted EBITDA.
In November 2023 the Group expanded the long-term incentive program to include senior management. Under the expanded program PSUs (Performance Share units) of the parent are granted to members of the Global Leadership Team members (GLT) and senior management. One PSU (instrument) equals one share. The eligible employees will be granted an annual award of shares from the company if certain performance criteria are met. The terms and conditions are unchanged from the long-term incentive program introduced in November 2022.
Elopak ASA was established with the share capital of NOK 376,906,620 (EUR 50,155,321) and the total number of shares outstanding for Elopak ASA is 269,219,014, each with a face value of NOK 1.4 (EUR 0.19).
At December 31, 2023, the company has a share capital of NOK 376,532,338 (EUR 50,104,463) and the total number of shares outstanding for Elopak ASA is 268,951,670, each with a face value of NOK 1.4 (EUR 0.19).
Elopak ASA's ordinary general meeting on May 11, 2023 approved a share buy-back program for the repurchase of up to NOK 37,690,662, meaning up to 26.9 million shares at nominal value of NOK 1.40/share. The shares acquired under the share buy-back program will be used to meet the Company's obligations towards employees who participate in the Company's long-term incentive plan. As of December 31, 2023, the balance of treasury shares is 267,344. The treasury share capital is EUR 51 thousand and the treasury share premium is EUR 545 thousand.
In 2017, the Norwegian tax office classified dividends from Elopak Systems AG as taxable income for Elopak ASA, and at the time the full tax amount of approximately 7 MEUR was recognized as a tax cost. Elopak ASA does not consider the distribution as taxable income. On June 22, 2023 the Oslo district court ruled in favor of the tax office, Elopak ASA has appealed the ruling.
Number of shares
| 2023 | Ordinary shares | Treasury | Ordinary shares | |
|---|---|---|---|---|
| issued | shares | outstanding | ||
| Shares at 1.1 | 269,219,014 | -5,519 | 269,213,495 | |
| Treasury shares purchased | - | -410,540 | -410,540 | |
| Treasury shares re-issued | - | 148,715 | 148,715 | |
| Shares at 31.12 | 269,219,014 | -267,344 | 268,951,670 |
| 2022 | Ordinary shares | Ordinary shares | |
|---|---|---|---|
| issued | Treasury shares | outstanding | |
| Shares at 1.1 | 269,219,014 | - | 269,219,014 |
| Treasury shares purchased | - | -170,000 | -170,000 |
| Treasury shares re-issued | - | 164,481 | 164,481 |
| Shares at 31.12 | 269,219,014 | -5,519 | 269,213,495 |
| Quarter ended December 31 | Year to date ended December 31 | ||||
|---|---|---|---|---|---|
| (EUR 1,000, except number of shares) | 2023 | 2022 | 2023 | 2022 | |
| Profit attributable to Elopak shareholders | 13,586 | 10,940 | 67,061 | 10,856 | |
| Issued ordinary shares at beginning of period, adjusted for share split in the period |
269,187,818 | 269,219,014 | 269,213,495 | 269,219,014 | |
| Effect of shares issued | -196,273 | -5,519 | -62,416 | -3,024 | |
| Weighted-average number of ordinary shares in the period | 268,991,545 | 269,213,495 | 269,151,079 | 269,215,990 | |
| Basic and diluted earnings per share attributable to Elopak shareholders (in EUR) |
0.05 | 0.04 | 0.25 | 0.04 |
| December 31, 2023 | December 31, 2022 | |||||
|---|---|---|---|---|---|---|
| (EUR 1,000) | Assets | Liabilities | Total | Assets | Liabilities | Total |
| Currency derivatives | 904 | 7,398 | -6,494 | 747 | 1,280 | -534 |
| Commodity derivatives | 31 | 2,408 | -2,377 | - | 3,318 | -3,318 |
| Interest derivatives | 3,650 | 2,105 | 1,545 | 7,063 | - | 7,063 |
| Total | 4,585 | 11,911 | -7,326 | 7,810 | 4,598 | 3,212 |
The full fair value of a derivative is classified as "Other non-current assets or "Other non-current liabilities" if the remaining maturity of the derivative is more than 12 months and, as "Other current assets" or "Other current liabilities", if the maturity of the derivative is less than 12 months. The fair value estimation of derivative financial instruments has been arrived at by applying a level 2 valuation methodology which uses inputs other than unadjusted quoted prices for identical assets and liabilities, with changes in fair value are therefore recognized in the income statement. No other material financial assets or liabilities are measured at fair value through profit or loss.
Where eligible, derivatives used for hedging are designated in cash flow hedge accounting relationships.
The Board will propose to the Annual General Meeting a dividend of NOK 1.46 per share for 2023.
The Group has signed contracts for Tethered Cap and other closure lines with an average lease term of 5 years and a nominal value of EUR 20,839 thousand, which will commence at different stages during 2024.
The Group prepares and reports its consolidated financial statements in accordance with International Financial Reporting Standards as issued by the IASB and as endorsed by the EU (IFRS). In addition, the Group presents several Alternative Performance Measures (APMs).
In accordance with European Securities and Market Authority (ESMA) guidelines dated May 10, 2015, an APM is understood as a financial measure of historical or future financial performance, financial position, or cash flows, other than a financial measure defined or specified in the applicable financial reporting framework (IFRS). It should be noted that these measures do not have any standardized meaning prescribed by IFRS and therefore are not necessarily comparable to the calculation of similar measures used by other companies. The APMs are regularly reviewed by the Group's management. The APMs are reported in addition to but are not substitutes for the Group's consolidated financial statements, prepared in accordance with IFRS.
The APMs provide supplementary information to measure the Group's performance and to enhance comparability between financial periods. The APMs also provide measures commonly reported and widely used by investors, lenders, and other stakeholders as an indicator of the Group's performance. These APMs are among other, used in planning for and forecasting future periods, including assessing our ability to incur and service debt including covenant compliance. APMs are defined consistently over time and are based on the Group's consolidated financial statements (IFRS).
Organic revenue is a measure of revenue adjusted for currency effects and effects of acquisition and disposal of operations. The Group presents this APM because management considers it to provide useful supplemental information for understanding the Group's revenue development over time for comparability purposes.
EBITDA is a measure of earnings before interest, taxes, depreciation, amortization, and impairments. The Group presents this APM because management considers it to provide useful supplemental information for understanding the overall picture of profit generation in the Group's operating activities and for comparing its operating performance with that of other companies.
Adjusted EBITDA is a measure of EBITDA adjusted for certain items affecting comparability (the Adjustment items) and further including the Group's share of net income from joint ventures (continued operations) presented as part of financial income and expenses. The Group presents this APM because management considers it to be an important supplemental measure for understanding the underlying profit generation in the Group's operating activities and comparing its operating performance with that of other companies.
Adjusted profit attributable to Elopak shareholders represents the Group's profit attributable to Elopak shareholders adjusted for certain items affecting comparability, taking into account the Adjustment items, related estimated calculatory tax effects based on a 24% statutory tax rate and excluding historical share of net income from joint
Alternative Performance Measures (APMs) ventures that have been discontinued. The Group presents this APM because management considers it to provide useful supplemental information for understanding the Group's profit attributable to Elopak shareholders and for comparability purposes with other companies.
Adjusted EPS represents adjusted profit attributable to Elopak shareholders divided by weighted average number of ordinary shares – basic and diluted. Elopak presents adjusted basic and diluted earnings per share because management considers it to be an important supplemental measure for understanding the Group's underlying profit for the year (period) on a per share basis and comparing its profit for the year (period) on a per share basis with that of other companies in the industry.
Net debt is a measure of borrowings (including liabilities to financial institutions before amortization costs and including lease liabilities) less cash and cash equivalents for the period. The Group presents this APM because management considers it as a useful indicator of the Group's indebtedness, financial flexibility and capital structure because it indicates the level of borrowings after taking into account cash and cash equivalents within the Group's business that could be utilized to pay down outstanding borrowings. Net debt is also used for monitoring the Group's financial covenants compliance by management.
Leverage ratio is a measure of net debt divided by adjusted EBITDA. The Group presents this APM because management considers it as a useful indicator of the Group's ability to meet its financial obligations. Net debt/adjusted EBITDA is also used for monitoring the Group's financial covenants compliance by management.
| Quarter ended December 31, | Year to date ended December 31, | ||||
|---|---|---|---|---|---|
| (EUR 1,000) | 2023 | 2022 | 2023 | 2022 | |
| Impairment fixed and long term assets Ukraine | - | 412 | - | 4,189 | |
| Impairment current assets Ukraine | - | 652 | - | 2,146 | |
| Onerous contracts | -100 | - | -100 | 100 | |
| Transaction costs | - | 38 | - | 2,888 | |
| Total adjusted items | -100 | 1,102 | -100 | 9,322 | |
| Calculatory tax effect 1) | 24 | -265 | 24 | 165 | |
| Total adjusted items net of tax | -76 | 838 | -76 | 9,487 |
| Quarter ended December 31, | Year to date ended December 31, | |||
|---|---|---|---|---|
| (EUR 1,000) | 2023 | 2022 | 2023 | 2022 |
| Total revenue and other operating income | 287,183 | 267,156 | 1,132,187 | 1,023,853 |
| Currency effect | 2,388 | -9,686 | 10,449 | -28,569 |
| Acquisition and disposal effect | - | -14,360 | -22,370 | -38,640 |
| Organic revenue | 289,570 | 243,110 | 1,120,266 | 956,644 |
| Organic revenue growth | 8.4% | 12.9% | 9.4% | 11.9% |
1) Calculatory tax effect on adjusted items at 24%
| Quarter ended December 31, | Year to date ended December 31, | |||
|---|---|---|---|---|
| (EUR 1,000) | 2023 | 2022 | 2023 | 2022 |
| Profit attributable to Elopak shareholders | 13,586 | 10,940 | 67,061 | 10,856 |
| Discontinued operations | - | - | 1,339 | 23,622 |
| Items excluded from adjusted EBITDA net of tax | -76 | 838 | -76 | 9,487 |
| Adjusted profit attributable to Elopak shareholders | 13,510 | 11,778 | 68,324 | 43,966 |
| Year to date ended December 31, | |||
|---|---|---|---|
| (EUR 1,000) | 2023 | 2022 | |
| Bank debt 1) | 225,000 | 305,000 | |
| Overdraft facilities | 19,333 | 21,682 | |
| Cash and equivalents | -13,308 | -25,883 | |
| Net bank debt | 231,025 | 300,799 | |
| Lease liabilities | 101,520 | 90,674 | |
| Net debt | 332,545 | 391,473 | |
| 1) Bank debt is excluding amortized borrowing costs of EUR 567 thousand as of December 31, 2023 and EUR 967 thousand as of December 31, 2022 | |||
| Leverage ratio 2) | 1.9 | 3.3 | |
2) Leverage ratio is calculated based on last twelve months adjusted EBITDA of EUR 170,867 thousand as of December 31, 2023 and EUR 119,413 thousand as of December 31, 2022.
| Quarter ended December 31, | Year to date ended December 31, | |||
|---|---|---|---|---|
| (EUR 1,000 except number of shares) | 2023 | 2022 | 2023 | 2022 |
| Weighted-average number of ordinary shares | 268,991,545 | 269,213,495 | 269,151,079 | 269,215,990 |
| Profit attributable to Elopak shareholders | 13,586 | 10,940 | 67,061 | 10,856 |
| Adjusted profit attributable to Elopak shareholders | 13,510 | 11,778 | 68,324 | 43,966 |
| Basic and diluted earnings per share attributable to Elopak shareholders (in EUR) |
0.05 | 0.04 | 0.25 | 0.04 |
| Adjusted basic and diluted earnings per share (in EUR) | 0.05 | 0.04 | 0.25 | 0.16 |
| Quarter ended December 31, | Year to date ended December 31, | |||
|---|---|---|---|---|
| (EUR 1,000) | 2023 | 2022 | 2023 | 2022 |
| Lala Elopak S.A. de C.V. | 1,946 | 504 | 4,730 | 2,665 |
| Impresora Del Yaque | 811 | 510 | 2,139 | 1,824 |
| Elopak Nampak Africa Ltd | -4 | -23 | -14 | -112 |
| Total share of profit joint ventures | 2,753 | 991 | 6,855 | 4,378 |
We confirm to the best of our knowledge that the condensed set of financial statements for the period January 1 to December 31, 2023, has been prepared in accordance with IAS 34 – Interim Financial Reporting, and gives a true and fair view of the Elopak Group's assets, liabilities, financial position and result for the period. We also confirm to the best of our knowledge that the financial review includes a fair review of significant events that have occurred during the financial period and their impact on the financial statements, any significant related parties transactions and a description of the principal risks and uncertainties for the financial period.
Skøyen, February 14, 2024 Board of Directors in Elopak ASA
Sanna Suvanto-Harsaae
Board member
Trond Solberg
Board member
Håvard Grande Urhamar
Board member
Anna Belfrage Board member
Anette Bauer Ellingsen Board member
Sid Johari
Board member
Thomas Körmendi CEO
Dag Mejdell
Chairperson
| Quarter ended December 31, | Year to date ended December 31, | |||
|---|---|---|---|---|
| (EUR 1,000) | 2023 | 2022 | 2023 | 2022 |
| Operating profit | 22,253 | 16,105 | 102,779 | 41,774 |
| Depreciation, amortization and impairment adjusted |
15,113 | 17,745 | 61,332 | 63,938 |
| Impairment fixed and long term assets Ukraine | - | 412 | - | 4,189 |
| EBITDA | 37,366 | 34,262 | 164,111 | 109,901 |
| Total adjusted items with EBITDA impact | -100 | 690 | -100 | 5,134 |
| Share of profit from joint ventures (continued oper ations) 2) 3) |
2,753 | 991 | 6,855 | 4,378 |
| Adjusted EBITDA | 40,019 | 35,943 | 170,867 | 119,412 |
2) Share of net income and impairment on investment from joint ventures included in adjusted figures
3) See reconciliation of net income from joint ventures
Mirza Koristovic Head of Investor Relations +47 938 70 525
Bent Axelsen Chief Financial Officer +47 977 56 578
The interim report contains certain forward-looking statements. Forward-looking statements are statements that are not historical facts and may be identified by words such as "plans", "targets", "aims", "believes", "expects", "anticipates", "intends", "estimates", "will", "may", "continues", "should" and similar expressions. Any statement, estimate or projections included in the Information (or upon which any of the conclusions contained herein are based) with respect to anticipated future performance (including, without limitation, any statement, estimate or projection with respect to the condition (financial or otherwise), prospects, business strategy, plans or objectives of the Group and/or any of its affiliates) reflect, at the time made, the Company's beliefs, intentions and current targets/aims and may prove not to be correct. Although the Company believes that these assumptions were reasonable when made, these assumptions are inherently subject to significant known and unknown risks, uncertainties, contingencies and other important factors which are difficult or impossible to predict and are beyond its control. No representation or warranty is given as to the completeness or accuracy of any forwardlooking statement contained in the Information or the accuracy of any of the underlying assumptions.
February 15, 2024 Quarterly Report – Q4 April 10, 2024 Annual Report May 8, 2024 Quarterly Report – Q1 May 13, 2024 Annual General Meeting May 14, 2024 Ex Dividend August 15, 2024 Half-yearly Report
Elopak reserves the right to revise the dates
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.